Download Edwards oximetry central venous catheter brochure

Early detection.
Proactive
intervention.
Edwards Oximetry
Central Venous Catheter
70%
ScvO2
Edwards oximetry central venous catheter (CVC) — the first proven CVC
with continuous ScvO2 monitoring — reveals the true adequacy of
tissue oxygenation for clarity in early assessment and intervention.
1–10
Edwards oximetry central venous catheter continuously monitors central venous oxygen saturation (ScvO2),
an early indicator of compromised or inadequate oxygen delivery.6–10
Continuous ScvO2 monitoring
Proactive management of tissue hypoxia6–10
Hemodynamic trends
ECG
150
100
90
MAP
90
60
30
CVP
10
5
0
SpO2
100
ScvO2
75
50
25
By providing a more sensitive
indicator of oxygen imbalance,
Edwards oximetry central venous
catheter identifies critical changes
earlier than traditional vital signs
and intermittent sampling—
enabling you to recognize and
prevent tissue hypoxia sooner.6–10
0 Hour
1.5 Hours
3 Hours
Helps guide therapy and provide real-time insight into the efficacy of intervention. 6,7
Demonstrated prognostic value of continuous ScvO2 monitoring. 11
• Post-op high-risk surgeries12
• Trauma9
• Sepsis13
• Cardiac failure in congenital heart failure10
• Recovery in cardiac arrest14–15
Continuous ScvO2 monitoring has multiple applications in intra- and post-op stages: 16,17
• Risk for high blood loss, such as hepatic resections, trauma, vascular cases
• High fluid shifts in gastrointestinal cases
• Toleration of single-lung ventilation in thoracic procedures
• Early indication of failure to tolerate extubation
The advantages of antimicrobial protection and
high-pressure injection, together in a single device.
Oligon integrated antimicrobial protection
Integrated Oligon antimicrobial material provides
enduring antimicrobial protection that will not wash
away like antimicrobial coatings. Silver ions (Ag+)
are released at a stable rate to attack microbes,
alter cell DNA and disrupt cell reproduction. The
resulting long-term release of silver into lumens and
subcutaneous spaces protects against gram-negative
and gram-positive bacteria, fungi and resistant
microorganism strains.18,19,20
High-pressure injection capability
Edwards oximetry central venous catheter is indicated
for high-pressure injection of contrast media for
visualization under imaging modalities such as CT,
MRI and fluoroscopy.18
For Oligon models only.
18,19
CO
Hb
Vasoactive medications
Inotropic medications
Dysrhythmia
Congestive heart failure
Shock
Hemorrhage
Occult bleeding
Anemia
Hemodilution
ScvO2
SaO2
VO2
Hypoxia/hypoxemia
Suctioning, atelectasis
Ventilation/oxygenation
Lung disease
Sepsis
Work of breathing
Fever, shivering
Pain/anxiety
Continuous ScvO2 monitoring reveals the root cause
of oxygen imbalance, allowing you to determine
appropriate therapy.6,21
Convenient, accurate and easy to use.6,17,22
Edwards oximetry central venous catheter provides:
Simplicity and flexibility — uses the same
insertion techniques as central lines 22
Continuous ScvO2 monitoring, pressure
monitoring and fluid resuscitation 2,18
Accurate oxygenation status 2,4
Edwards Oximetry
Central Venous
Catheter with
Integrated Oligon
Antimicrobial
Protection
Edwards Oximetry
Central Venous
Catheter
References inserted above
See clearly. Stay ahead.
Designed for use with Edwards’ monitoring platforms, Edwards’ oximetry central venous catheters
offer the clarity of an early warning to support early intervention.
Edwards Oximetry Central
Venous Catheter with Integrated
Oligon Antimicrobial Protection
Early assessment with real-time
ScvO2 monitoring enables you to
make proactive clinical decisions
for your high-risk patients.6,7
Edwards EV1000
Clinical Platform
PediaSat
Oximetry Catheter
Presents patient physiologic
status in an intuitive, meaningful
way to clinically support proactive
hemodynamic management.
The first and only pediatric
oximetry catheter with
continuous ScvO2 monitoring
to help you stay ahead of
hypoxia and stages of sepsis.11,23–25
Edwards oximetry central venous catheter
Lumens
Length (CM)
Oligon
Region
X3816KT
3
16
US
X3820KT
3
20
US
XA3816KT
3
16
X
US
XA3816SAFKT
3
16
X
US
XA3820KT
3
20
X
US
XA3820SAFKT
3
20
X
US
For over 40 years, Edwards Lifesciences has been helping you make proactive clinical decisions to
advance the care of surgical and critical care patients.
Through ongoing collaboration with you, ongoing education and our never-ending quest for advancement,
Edwards develops solutions that provide the clarity to make proactive clinical decisions.
Know more. Visit Edwards.com/OximetryCVC
CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use
for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
Edwards, Edwards Lifesciences, the stylized E logo, EV1000, PediaSat, and PreSep are trademarks of Edwards Lifesciences
Corporation or its affiliates. All other trademarks are the property of their respective owners.
© 2016 Edwards Lifesciences Corporation. All rights reserved. PP--US-1378
Edwards Lifesciences • One Edwards Way, Irvine CA 92614 USA • edwards.com
References for Edwards oximetry
central venous catheter brochure
1. Edwards Oximetry Central Venous Catheter
Instructions for Use
2. Clinical PreSep PediaSat Clinical Evaluation Report.
3. FDA 510k K053609
4. FDA 510k K061585
5. FDA 510k K091786
6. Reinhart K, et al. Continuous central venous and
pulmonary artery oxygen saturation monitoring in the
critically ill. Intensive Care Med. 2004;30(8):1572-8.
7. Rivers EP, et al. Central venous oxygen saturation
monitoring in the critically ill patient. Curr Opin Crit
Care. 2001;7(3):204-11.
8. Ingelmo P, et al. Importance of monitoring in
high risk surgical patients. Minerva Anestesiol.
2002;68(4):226-30.
9. Scalea, TM, et al. Central venous oxygen saturation:
a useful clinical tool in trauma patients. J Trauma
1990;30(12):1539-43.
10. Ander, DS, et al. Undetected cardiogenic shock in
patients with congestive heart failure presenting
to the emergency department. Am J Cardiol
1998;82(7):888-91.
11. Spenceley, N., et al. Continuous central venous
saturations during pericardial tamponade case report.
Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.153.
12. Pearse, R, et al. Changes in central venous saturation
after major surgery, and association with outcome.
Crit Care 2005;9(6):R694-91.
13. Rady, MY, et al. Resuscitation of the critically ill in the
ED: responses of blood pressure, heart rate, shock
index, central venous oxygen saturation, and lactate.
Am J Emerg Med 1996;14(2):218-25.
14. Rivers, EP, et al. The clinical implications of continuous
central venous oxygen saturation during human CPR.
Ann Emerg Med 1992;21(9):1094-101.
15. Nakazawa, K, et al. Usefulness of central venous oxygen
saturation monitoring during cardiopulmonary
resuscitation. A comparative case study with endtidal carbon dioxide monitoring. Intensive Care Med
1994;20(6):450-1.
16. Noguiera P, et al. Central Venous Saturation:
A Prognostic Tool in Cardiac Surgery Patients.
J Intensive Care Med. 2010;25(2):111-116.
17. Vallet B, et al. Venous oxygen saturation as a
physiologic transfusion trigger. Crit Care. 2010;14:213.
18. FDA 510k Edwards Oximetry Central Venous Catheter
(K160645)
19. US Patent #4411648
20. Edwards Oligon Oximetry Catheters contain an
integrated Oligon antimicrobial material. The
activity of the antimicrobial agent is localized
at the catheter surfaces and is not intended for
treatment of systemic infections. In vitro testing
demonstrated that the Oligon material provided
broad-spectrum effectiveness (≥ 3 log reduction
from initial concentration within 48 hours) against
the organisms tested: Staphylococcus aureus,
Staphylococcus epidermidis, Klebsiella pneumoniae,
Enterococcus faecalis, Candida albicans, Escherichia
coli, Serratia marcescens, Acinetobacter calcoaceticus,
Corynebacterium diphtheriae, Enterobacter aerogenes,
GMRSa, Pseudomonas aeruginosa, Candida glabrata and
VRE (Enterococcus faecium).
21. Zaja J. Venous oximetry. Signa Vitae 2007;2(1):6-10.
22. Mahajan A, et al. An experimental and clinical
evaluation of a novel central venous catheter with
integrated oximetry for pediatric patients undergoing
cardiac surgery. Pediatric Central Venous Oximetry.
Anest Anal. 2007;Vol.105, No. 6, 1598.
23. Krahn, G., et al. Early clinical evaluation of the Edwards
PediaSat™ oximetry catheter in pediatric patients.
Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.152.
24. Spenceley, N., et al. Continuous central venous
saturation monitoring in pediatrics: a case report.
Pediatr Crit Care Med 2008, Vol. 9, No. 2, p e13-e16
25. Lemson et al. Advanced hemodynamic monitoring in
critically ill patients. Pediatrics. 2011.
CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician.
See instructions for use for full prescribing information, including indications, contraindications,
warnings, precautions and adverse events.
Edwards, Edwards Lifesciences, the stylized E logo, PediaSat, and PreSep are trademarks of Edwards Lifesciences
Corporation or its affiliates. All other trademarks are the property of their respective owners.
© 2016 Edwards Lifesciences Corporation. All rights reserved. PP--US-1378
Edwards Lifesciences • One Edwards Way, Irvine CA 92614 USA • edwards.com